The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

A••••• T••••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor unattributed
Also written as: 2022; 5; 5/9/2022; 9; Equity; Inc. - Common Stock
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. No dated change on record yet.

Mark path, consensus per quarter end
Q2 2025: 100¢Q3 2025: 101¢Q4 2025: 101¢Q1 2026: 101¢Q2 2026: 101¢100¢ · 101¢ · 101¢ · 101¢ · 101¢Q2 2025 to Q2 2026
Where each lender marks it, 0 points apart
101¢Consensus: 101¢B••••••••• P•••••• C••••• F•••: 101¢B••••••••• S•••••• L•••••• F•••: 101¢101¢
Principal held
at least $114M
sum of BDC pieces, a lower bound
Fair value
$117M
101c on cost, debt pieces
Unfunded
$66.0M
commitments not yet drawn
BDC lenders
3
3 on the latest quarter
Facilities
4
2 equity pieces beside them
Next maturity
May 8, 2030
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
5
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
LenderExposureCurrent markQoQ change
B••••••••• P•••••• C••••• F•••$95.4M101¢0 pts
B••••••••• S•••••• L•••••• F•••$18.6M101¢0 pts
Every BDC piece · 9 positions across 3 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
B••••••••• P•••••• C••••• F•••delayed draw term loan lien unstated
N••••••••• I•••••
$60.3M$60.3M
101c
S+475 bp
B••••••••• P•••••• C••••• F•••delayed draw term loan lien unstated
N••••••••• I•••••
$35.2M$35.2M
101c
S+400 bp
B••••••••• S•••••• L•••••• F•••delayed draw term loan lien unstated
N••••••••• I•••••
$11.7M$11.7M
101c
S+475 bp
B••••••••• S•••••• L•••••• F•••delayed draw term loan lien unstated
N••••••••• I•••••
$6.8M$6.8M
101c
S+400 bp
B••••••••• P•••••• C••••• F•••revolver lien unstated
R•••••••
Not disclosedNot disclosed
View all 9 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
B••••••••• P•••••• C••••• F•••delayed draw term loan lien unstated
D•••••• D••• T••• L•••
Not disclosedNot disclosed
B••••••••• S•••••• L•••••• F•••revolver lien unstated
R•••••••
Not disclosedNot disclosed
B••••••••• S•••••• L•••••• F•••delayed draw term loan lien unstated
D•••••• D••• T••• L•••
Not disclosedNot disclosed
H••••••• C••••••• I•••warrants equity
W••••••, 1/9/2023, C••••• S••••
Not disclosed$2.7M
652c
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
delayed draw term loan lien unstatedat least $114M101cS+475 bpMay 8, 20302
revolver lien unstatedunknownn/aunstated2
first lien term loan first lien
exited Mar 31, 2025
at least $143M105cS+220 bpJan 1, 20281
other lien unstated
exited Jun 30, 2025
at least $114M100cS+475 bpMay 8, 20302
Equity pieces beside the debt: warrants ($2.7M fair value, 1 BDC), equity ($2.5M fair value, 3 BDCs)
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20263$114M$114M101c0
Mar 31, 20263$114M$114M101c0
Dec 31, 20253$114M$114M101c0
Sep 30, 20253$114M$114M101c0
All 15 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20253$114M$113M100c0
Mar 31, 20251$143M$153M105c0
Dec 31, 20241$287M$306M105c0
Sep 30, 20241$143M$152M105c0
Jun 30, 20241$143M$152M105c0
Mar 31, 20241$143M$150M104c0
Dec 31, 20231$430M$451M105c0
Sep 30, 20231$143M$148M103c0
Jun 30, 20231$143M$144M101c0
Mar 31, 20231$122M$121M100c0
Dec 31, 20221$81.7M$78.1M96c0
What changed
Full timeline · 6 events
Every change including routine ones
Identity
Group key
A••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 3 BDCsderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it